Sluggish donor response to CEPI’s pandemic prevention ask
Lassa fever: CEPI aims to launch Phase 3 clinical trials of Lassa fever vaccine as part of its coming five-year strategy. (Photo by CEPI)
For subscribers, please log in. To become a subscriber or to read one free article, click below.